Severe Dysphagia Linked to Shorter Survival and Higher Mortality After Percutaneous Endoscopic Gastrostomy: Study
Japan: A recent study found that severe dysphagia in patients undergoing percutaneous endoscopic gastrostomy (PEG) was linked to a nearly threefold increased risk of mortality (hazard ratio, 2.95).
"Patients with severe dysphagia (Hyodo-Komagane score ≥9) experienced significantly poorer survival outcomes compared to those with moderate dysphagia (score ≤8). Aspiration-related pneumonia was the leading cause of death among these patients," the researchers reported in Scientific Reports.
The researchers note that percutaneous endoscopic gastrostomy is a commonly performed procedure that provides long-term enteral nutrition for patients who are unable to eat due to conditions such as neurological disorders, head and neck cancers, and stroke. While PEG is a life-saving intervention, the overall survival outcomes of these patients can be significantly affected by several factors, including the severity of dysphagia.
Dysphagia, or difficulty swallowing, is a common symptom among individuals requiring PEG. It is often associated with a range of underlying medical conditions, particularly those affecting the central nervous system, such as stroke, Parkinson's disease, and dementia. For patients undergoing PEG, the degree of dysphagia plays a crucial role in determining post-procedure survival.
Against the above background, Kazumi Shimamoto, Department of Gastroenterology, Omi Medical Center, Kusatsu, Shiga, Japan, and colleagues examined the impact of severe dysphagia on the overall survival of patients undergoing PEG.
For this purpose, the researchers retrospectively analyzed a cohort of patients who underwent PEG between 2016 and 2021. Swallowing ability was assessed using the Hyodo–Komagane score via endoscopy. Patients with a score ≤8 were classified as having moderate dysphagia, while those with a score ≥9 were classified as having severe dysphagia. The primary outcome was overall survival, with prognostic factors identified through multivariate analysis using the Cox proportional hazards model.
The study revealed the following findings:
- Among the 107 patients, 60 (56.1%) were classified into the moderate dysphagia group and 47 (43.9%) into the severe dysphagia group. The median follow-up period was 16.7 months.
- Overall survival was significantly worse in the severe dysphagia group compared to the moderate dysphagia group.
- Multivariate analysis identified severe dysphagia as an independent poor prognostic factor (hazard ratio, 2.956).
"The study, though limited by its single-center, retrospective design, and small sample size, provides valuable insights into the impact of severe dysphagia on overall survival in patients undergoing percutaneous endoscopic gastrostomy. The findings highlight that severe dysphagia is an independent poor prognostic factor for OS, underscoring the need for careful consideration of long-term survival outcomes in these patients," the researchers wrote.
"While improving swallowing function remains challenging, PEG may still offer quality-of-life benefits for those in severe pain from nasogastric tubes. However, aspiration prevention surgery should be explored as a treatment option for patients with severe dysphagia. These findings, as first demonstrated by the authors, emphasize the importance of individualized care in managing dysphagia post-PEG, they concluded.
Reference:
Shimamoto, K., Matsui, R., Nishiyama, Y., Nishino, K., & Ban, H. (2025). Impact of severe dysphagia on overall survival after percutaneous endoscopic gastrostomy. Scientific Reports, 15(1), 1-8. https://doi.org/10.1038/s41598-025-88097-y
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.